Identification of variants influences treatment decisions. Inhibitors of the poly-ADP-ribose polymerase (PARP) system, a pathway for repairing single-stranded DNA breaks, are recommended for tumors ...
Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.
Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone Outcomes data for DNA-damaging ...
Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results